Cargando…
Calcimimetic Use in Familial Hypocalciuric Hypercalcemia—A Perspective in Endocrinology
CONTEXT: Familial hypocalciuric hypercalcemia (FHH) causes lifelong hypercalcemia that even persists after subtotal parathyroidectomy. Symptoms are usually mild. Past recommendations have often been for monitoring and against surgical or pharmacologic treatments. METHODS: Review of publications abou...
Autor principal: | Marx, Stephen J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673268/ https://www.ncbi.nlm.nih.gov/pubmed/28945857 http://dx.doi.org/10.1210/jc.2017-01606 |
Ejemplares similares
-
MON-258 Toddler with Hypercalcemia: Diagnosis of Familial Hypocalciuric Hypercalcemia
por: Kochanski, Justin, et al.
Publicado: (2019) -
Severe Symptomatic Hypercalcemia in a Patient With Familial Hypocalciuric Hypercalcemia
por: Kurian, Roshini, et al.
Publicado: (2021) -
Case Report: Severe Neonatal Course in Paternally Derived Familial Hypocalciuric Hypercalcemia
por: Höppner, Jakob, et al.
Publicado: (2021) -
Successful prednisolone or calcimimetic treatment of acquired hypocalciuric hypercalcemia caused by biased allosteric CaSR autoantibodies
por: Makita, Noriko, et al.
Publicado: (2022) -
A Case of Lithium-Associated Hypocalciuric Hypercalcemia
por: Nwabufor, Philip C, et al.
Publicado: (2020)